Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7141-7150 of 13156

Page
per page
  1. Purvalanol A
    B4990 Purvalanol A
    Summary: potent, and cell-permeable CDK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.45 mg/mL
  2. Fruquintinib(HMPL-013)
    B5864 Fruquintinib(HMPL-013)
    Target: VEGFR
    Summary: Potent and selective inhibitor of VEGFR 1, 2, 3
      insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
  3. CL-387785 (EKI-785)
    B5899 CL-387785 (EKI-785)
    Summary: Irreversible inhibiter of EGFR
      insoluble in EtOH; insoluble in H2O; ≥16.85 mg/mL
  4. MS049 (hydrochloride)
    C3776 MS049 (hydrochloride)
    Summary: PRMT4 and PRMT6 inhibitor
      ≤30 mg/mL
  5. AVE-1625
    C4753 AVE-1625
    Summary: highly potent, selective antagonist for CB1 receptor
      ≤0.15 mg/mL
  6. SR 2595
    C5572 SR 2595
    Summary: inverse agonist of PPARγ
      ≤5 mg/mL
  7. Iloperidone hydrochloride
    B1203 Iloperidone hydrochloride
    Summary: D(2)/5-HT(2) receptor antagonistis
      Soluble in DMSO
  8. immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]
    A1072 immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]
    Summary: Immunoglobulin light chain fragment
      ≥112.2 mg/mL
  9. Nexturastat A
    B3704 Nexturastat A
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,highly potent and selective
      insoluble in H2O; ≥16.3 mg/mL
  10. PI-3065
    B4660 PI-3065
    Target: PI3K
    Summary: P110δkinase inhibitor
      ≥22.7 mg/mL

Items 7141-7150 of 13156

Page
per page